Back to Condition
ADNP syndrome
Reviewed by Medicinsk Expert•Last updated: 2026-10-22•Condition

ADNP syndrome

ADNP syndrome is a genetic condition characterized by intellectual disability, autism spectrum disorder, and distinctive facial features.

Overview

ADNP syndrome causes a wide variety of signs and symptoms. Its hallmark features are intellectual disability and autism spectrum disorder, which is characterized by impaired communication and social interaction. Affected individuals often have distinctive facial features and abnormalities across multiple body systems.

Symptoms

Individuals with ADNP syndrome may experience a range of health and developmental challenges:

  • Developmental Delay: Mild to severe intellectual disability and delays in speech and motor skills, such as sitting and walking.
  • Behavioral Issues: Characteristics of autism spectrum disorder, including repetitive behaviors, anxiety, temper tantrums, attention-deficit/hyperactivity disorder (ADHD), obsessive-compulsive disorder, and sleep problems.
  • Facial Features: A prominent forehead, high hairline, upslanting or downslanting eyes, droopy eyelids (ptosis), a broad nasal bridge, and a thin upper lip.
  • Physical Abnormalities: Unusually shaped ears, hand and finger abnormalities, and early eruption of baby teeth.
  • Vision and Sensory: Strabismus (eyes not pointing in the same direction) and farsightedness.
  • Systemic Issues: Weak muscle tone (hypotonia), feeding difficulties, digestive problems (such as acid reflux, vomiting, and constipation), obesity, seizures, and heart abnormalities.

Causes

ADNP syndrome is caused by mutations in the ADNP gene. The protein produced by this gene is involved in chromatin remodeling, a process that regulates gene expression by controlling how DNA is packaged. By regulating gene expression, the ADNP protein is essential for normal brain development and the function of other body systems. Mutations in this gene disrupt chromatin remodeling, altering the activity of many genes and leading to the diverse symptoms of the syndrome.

Inheritance

ADNP syndrome is not inherited. It results from new (de novo) mutations in the ADNP gene that occur during the formation of reproductive cells or in early embryonic development. The condition occurs in individuals with no family history of the disorder.

Frequently Asked Questions

definitive diagnosis is made by detecting a pathogenic variant in the ADNP gene through DNA analysis. Blood (or saliva) is collected for a targeted ADNP gene test, a clinical exome panel, or whole‑exome sequencing. Results are usually reported within 4–6 weeks.
Yes. Behavioral interventions such as Applied Behavior Analysis (ABA), social skills groups, and sensory integration therapy have shown benefit. In addition, structured routines, visual supports, and, when appropriate, low‑dose atypical antipsychotics (e.g., risperidone) can help with severe irritability or self‑injurious behavior. Collaboration with a developmental‑behavioral pediatrician ensures the plan is individualized.
Early, intensive speech‑language therapy that incorporates augmentative and alternative communication (AAC) devices can accelerate language acquisition. Occupational therapy focusing on fine‑motor skills, plus physiotherapy for gross‑motor milestones (sitting, crawling, walking), should start as soon as delays are noted. Many families benefit from a multidisciplinary early‑intervention program that coordinates these services.
Children should have baseline and annual cardiac evaluation (echocardiogram) because congenital heart defects occur in ~10 % of cases. EEG monitoring is advised if seizures are suspected, and ophthalmology exams are needed for strabismus or optic nerve issues. Gastrointestinal follow‑up for reflux, constipation, and feeding difficulties is also recommended.
Source: MedlinePlus, National Library of Medicine

MedlinePlus brings together authoritative health information from the National Library of Medicine (NLM), the National Institutes of Health (NIH), and other government agencies and health-related organizations.

kontakt@hittavard.se

Ⓒ 2024. Alla rättigheter förbehålls av juxt ab